MedPath

Manual Dexterity Control After Cerebellar Stimulation

Not Applicable
Conditions
Stroke
Interventions
Device: With stimulation
Device: No stimulation
Registration Number
NCT03092570
Lead Sponsor
Centre Hospitalier St Anne
Brief Summary

This study will assess the putative advantages of cerebellar stimulation on motor learning abilities of stroke patients. In order to have a control group to refer to, the effect of cerebellar stimulation on healthy young and old participants will also be assessed.

Detailed Description

Cerebrovascular accidents (CVA) are the first cause of acquired disability in France. Despite rehabilitation interventions, a great proportion of patients suffers from motor disability in the upper limb. Recently, several studies have shown that post CVA patients exhibit great neural plasticity as a direct consequence of their condition.

Interestingly, the transcranial direct current stimulation (tDCS) is a non-invasive electro stimulation technique that allows for a modulation of cerebral activity. It has been shown that when applied to the cerebellum, tDCS increases learning performances of healthy subjects. Yet, motor rehabilitation after a CVA highly relies on motor (re)learning. The cerebellar tDCS thus appear as a promising method to enhance the performance of post-CVA motor learning and consequently the benefits of post-CVA rehabilitation.

The current study aims to promote the post CVA neural plasticity by using the tDCS in order to enhance motor learning of the upper limb.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Right-handed
  • Affiliated to the French health insurance or similar organisation
  • Signed informed consent
  • Clinical examination

For "Post-AVC patients" :

  • at least 18 years old
  • completed the Moberg Pick-up test with a minimum score of 20 secondes For "Young healthy" group
  • 18 = or > years = or <30 For "Older healthy" group
  • 50 > or = years = or < 80
Exclusion Criteria
  • Metallic implant in the head
  • Pacemaker, or other electronic implanted devices
  • Other central neurological disease
  • Pregnancy, breast feeding
  • Previous history of neurosurgery or seizures or 1st degree relative with history of seizures
  • History of medical neurological or psychiatric disorders
  • Participation to another study using cerebral stimulation
  • History of bi-polar or recurring depressive disorders
  • Planned carotid revascularization, severe caridac disease
  • Kidney failure (transaminase > 2 times normal value)
  • Other invalidating condition or deficiency interfering with the study

For "Post-AVC patients" :

  • NIHSS score > 20
  • Cerebellar ischemic CVA

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
tDCS Older HealthyWith stimulationThe participants will get a 20min stimulation at a maximal intensity of 2mA
tDCS Post-CVAWith stimulationThe participants will get a 20min stimulation at a maximal intensity of 2mA
Sham Young HealthyNo stimulationThe tDCS will be placed as for the Experimental group and will last 30 seconds at the beginning of task
Sham Post-CVANo stimulationThe tDCS will be placed as for the Experimental group and will last 30 seconds at the beginning of task
Sham Older HealthyNo stimulationThe tDCS will be placed as for the Experimental group and will last 30 seconds at the beginning of task
tDCS Young HealthyWith stimulationThe participants will get a 20min stimulation at a maximal intensity of 2mA
Primary Outcome Measures
NameTimeMethod
Force controlDay 10

Measurement in Newton of the force applied by each finger.

OverflowDay 10

Measurement in ms of the involuntary finger movements.

Secondary Outcome Measures
NameTimeMethod
Finger time releaseDay 10

Time needed to release the finger force when needed (in ms).

Action Research Arm TestDay 10

Assessment of the upper limb mobility. One score will be given at the end of the test

Moberg Pick-up TestDay 10

Assessment of the functionality of the hand. One score will be given at the end of the test.

Trial Locations

Locations (2)

Centre de Recherche Clinique (CRC) - CHSA

🇫🇷

Paris, France

Service de Médecine Physique et Rédaptation

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath